Buzz Stocks: Deere & Company, HP Inc, and BioMarin Pharmaceuticals Inc.

Today's stocks to watch include Deere & Company (DE), HP Inc (HPQ), and BioMarin Pharmaceutical Inc. BMRN)

Nov 25, 2015 at 9:44 AM

BMRN
HPE
HPQ
DE

U.S. stocks are pointed higher this morning on a fresh round of economic data, even as crude oil slides back from yesterday's win. Among the equities in focus are agricultural equipment maker Deere & Company (NYSE:DE), tech concern HP Inc (NYSE:HPQ), and biotech interest BioMarin Pharmaceutical Inc. (NASDAQ:BMRN).

DE is 4.5% higher at $79.80 this morning, after announcing quarterly earnings that beat estimates on the Street, even though revenue fell short. The last time Deere & Company reported earnings -- in late August -- it forecast lower sales for the 2015 fiscal year, sending the shares to a one-day loss of 8.1%. This time around, though, bears could be sweating; currently, 12% of DE's float is sold short, and it would take nearly two full weeks of trading to cover those positions at the stock's typical daily volume.

HPQ reported quarterly earnings last night, for the first time since the company began trading separately from Hewlett-Packard Enterprise Co (NYSE:HPE). Unfortunately, earnings and revenue came in below expectations, dropping HP Inc 12.8% to $12.77 this morning. The company has been having a rough time for most of the year, losing nearly one-third of its value so far in 2015, and underperforming the S&P 500 Index (SPX) by more than 50 percentage points over the past three months -- though the shares have been trending higher since the company split. Options traders have remained pessimistic, as the stock's 10-day put/call volume ratio at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) is just one percentage point shy of a 52-week high, at 2.99.

It's a disappointing morning for BMRN, as the U.S. Food and Drug Administration (FDA) reported that data on its muscle wastage treatment is not strong enough for approval. Today the shares have shed 2.9% to trade at $94.99. Just last week, the FDA raised questions over the effects of the same drug in young children. The company is up 5.1% so far this year, but has lost about one-third of its value since hitting a high of $151.75 in July.

Follow @Schaeffers

The $25K Day Trading Barrier is Gone

The long-standing Pattern Day Trader (PDT) rule that required many traders to maintain a $25,000 account balance is no longer standing in the way.

That means more traders can actively pursue short-term opportunities without the barrier that kept so many on the sidelines.

Now it's all about having the right strategy.

Dynamite Day Trading Signals helps you hit the ground running with up 2 options trade alerts per week, built to capture fast-moving opportunities.

👉 Sign up now to receive the next trade